AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Growth in Short Interest

AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) saw a significant increase in short interest in May. As of May 15th, there was short interest totalling 1,850,000 shares, an increase of 24.2% from the April 30th total of 1,490,000 shares. Approximately 4.8% of the shares of the stock are short sold. Based on an average daily volume of 494,500 shares, the days-to-cover ratio is presently 3.7 days.

Analyst Ratings Changes

Separately, HC Wainwright restated a "buy" rating and issued a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

Hedge Funds Weigh In On AngioDynamics

Several large investors have recently added to or reduced their stakes in ANGO. SBI Securities Co. Ltd. purchased a new position in AngioDynamics during the fourth quarter worth about $28,000. US Bancorp DE lifted its position in AngioDynamics by 1,938.0% during the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier's stock worth $61,000 after buying an additional 6,376 shares during the period. Quinn Opportunity Partners LLC purchased a new position in AngioDynamics during the fourth quarter worth about $92,000. ProShare Advisors LLC purchased a new position in AngioDynamics during the fourth quarter worth about $100,000. Finally, Graham Capital Management L.P. purchased a new position in AngioDynamics during the fourth quarter worth about $106,000. 89.43% of the stock is currently owned by hedge funds and other institutional investors.

AngioDynamics Trading Up 0.9%

Shares of NASDAQ:ANGO traded up $0.10 on Friday, hitting $11.06. The company had a trading volume of 765,700 shares, compared to its average volume of 573,297. AngioDynamics has a 52-week low of $5.47 and a 52-week high of $13.50. The business has a 50 day moving average of $9.55 and a 200 day moving average of $9.67. The company has a market cap of $449.11 million, a PE ratio of -1.96 and a beta of 0.62.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last issued its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The business had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. AngioDynamics's quarterly revenue was down 4.3% compared to the same quarter last year. As a group, equities analysts predict that AngioDynamics will post -0.37 EPS for the current year.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.